Month: September 2025

VISTA, Calif., Sept. 09, 2025 (GLOBE NEWSWIRE) — Flux Power Holdings, Inc. (NASDAQ: FLUX), a leading developer of advanced lithium-ion energy storage solutions for industrial applications, will report its fourth quarter and fiscal year 2025 results on Tuesday, September 16, 2025, after market close. Krishna Vanka, Chief Executive Officer, Kevin Royal, Chief Financial Officer, and Kelly Frey, Chief Revenue Officer, will host a conference call at 4:30 p.m. ET to discuss the Company’s financial results, followed by a question-and-answer session. Analysts and investors are invited to join the conference call using the following information:Date: Tuesday, September 16, 2025Time: 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time)Conference Call Number: 1-833-630-1956International Call Number: +1-412-317-1837 Additionally, this conference...

New mobile app brings enterprise-grade AI call assistance directly to professionals SINGAPORE and SAN DIEGO, Sept. 09, 2025 (GLOBE NEWSWIRE) — Helport AI Limited (NASDAQ: HPAI) (“Helport AI” or the “Company”), an AI technology company serving enterprise clients with intelligent customer communication software and services, today announced the launch of HelportGo, its flagship mobile application designed to improve productivity for on-the-go professionals.  With HelportGo, Helport AI extends its enterprise-grade AI capabilities directly to individual users on demand, aiming to offer immediate, transformative call assistance to facilitate conversion of conversation into structured, actionable business intelligence.  This launch marks a significant milestone in Helport AI’s strategic expansion beyond enterprise clients, solidifying...

Live Presentation to be Webcast Today at 9am ET HINGHAM, Mass., Sept. 09, 2025 (GLOBE NEWSWIRE) — Microbot Medical Inc. (Nasdaq: MBOT), developer and manufacturer of the innovative LIBERTY® Endovascular Robotic System, today announced that Harel Gadot, CEO, President & Chairman, will highlight the recent FDA clearance of the LIBERTY® System, the first single-use, remotely operated robotic system for peripheral endovascular procedures, at the H.C. Wainwright Annual Investor Conference. The Company’s presentation will be delivered today, September 9th at 9:00am ET, and a live webcast may be accessed via the ‘Events’ section of the Company’s website at www.microbotmedical.com. About Microbot Medical Microbot Medical Inc. (NASDAQ: MBOT) is a breakthrough medical device company focused on transforming endovascular procedures through...

COLUMBUS, Ohio, Sept. 09, 2025 (GLOBE NEWSWIRE) — Worthington Enterprises Inc. (NYSE: WOR) will hold its quarterly earnings conference call Wednesday, September 24 at 8:30 a.m. ET. The Company will discuss its fiscal first quarter results, which will be released after the market closes on September 23. Please click here to register for the September 24 live audio webcast or visit IR.worthingtonenterprises.com. For those unable to listen live, a replay will be available in the Investors section of the Company’s website approximately two hours after the completion of the call and will be archived for one year.LIVE CONFERENCE CALL DETAILSDate: Wednesday, September 24, 2025Webcast Link: https://events.q4inc.com/attendee/580719185Starting Time: 8:30 a.m. ETConference ID: 1777337Domestic Participants: 888-330-3567   About...

Additional patent granted from the Japanese patent office now results in 20 granted patents and allowed applications covering the compound and its underlying technology SOUTH SAN FRANSCISCO, Calif., Sept. 09, 2025 (GLOBE NEWSWIRE) — CERo Therapeutics Holdings, Inc., (Nasdaq: CERO) (“CERo” or the “Company”) an innovative cellular immunotherapy company seeking to advance the next generation of engineered T cell therapeutics that employ phagocytic mechanisms,  announces the Company received a Notice of Allowance from the U.S. Patent and Trademark Office for its Application 19/019,111.  The patent that will issue will provide the Company with both composition of matter protection for CER-1236 and protection for the use of CER-1236 to treat cancer, through 2041. Upon issuance, this patent will provide the most comprehensive protection...

Kfar Saba, Israel, Sept. 09, 2025 (GLOBE NEWSWIRE) — ParaZero Technologies Ltd. (Nasdaq: PRZO) (the “company” or “ParaZero”), an aerospace defense company pioneering smart, autonomous solutions for the global manned and unmanned aerial systems (UAS) industry, today announced the successful completion of a joint field trial of its DropAir system for the precision delivery of blood units. The trial was conducted in collaboration with MAFAT (the Israeli Ministry of Defense Directorate of Defense R&D), the Israeli Ministry of Health, and the Israel Defense Forces (IDF), including the Medical Corps and Technology & Logistics Directorate (ATAL). During the trial, blood Transfusions were dropped from an altitude of 200 meters AGL using ParaZero’s DropAir system. Following recovery, the Transfusions were inspected by doctors...

New RWA Consultancy Expected to Diversify Revenues, Enhance Margins, and Strengthen VCIG’s Cross-Sector Growth Sector KUALA LUMPUR, Malaysia, Sept. 09, 2025 (GLOBE NEWSWIRE) — VCI Global Limited (NASDAQ: VCIG) (“VCI Global” or the “Company”), today announced that its subsidiary, Smart Bridge Technologies Limited (“Smart Bridge”), has launched a dedicated Real-World Asset (RWA) consultancy to capture share in the US$16 trillion tokenization market projected by Boston Consulting Group and ADDX. The launch marks a strategic expansion of VCI Global’s cross-sector platform, which integrates capital markets consultancy, AI, fintech, and cybersecurity. With Smart Bridge, the Company is extending its reach into the fast-growing tokenization space, unlocking opportunities where traditional finance and digital assets converge. Smart Bridge...

Charlotte, NC, Sept. 09, 2025 (GLOBE NEWSWIRE) — FG Nexus Inc. (Nasdaq: FGNX, FGNXP) (the “Company”), today announced that its Board of Directors has approved a Share repurchase program to acquire up to $200 million of the Company’s outstanding common stock (the “Share Repurchase Program”). The Stock Repurchase Program, which is open-ended, allows the Company to repurchase its shares from time to time in the open market and in negotiated transactions. Any repurchases conducted pursuant to the Share Repurchase Program will be in accordance with Rule 10b-18 of the Exchange Act and will be made in accordance with applicable laws and regulations in effect from time to time. “The Share Repurchase Program reflects our confidence in FG Nexus’s long-term prospects and our commitment to delivering value to shareholders”...

New AI-enabled digital tool empowers patients to confidently manage IBS symptoms and avoid the trigger foods identified by inFoods® IBS testing IBS affects an estimated 40 million adults in the U.S. and hundreds of millions worldwideIRVINE, Calif., Sept. 09, 2025 (GLOBE NEWSWIRE) — Biomerica, Inc. (Nasdaq: BMRA), a global provider of advanced diagnostic and therapeutic solutions, today announced the launch of its inFoods® IBS Trigger Food Navigator, a comprehensive AI-backed digital companion tool designed to better enable patient dietary compliance and improve treatment success for individuals with Irritable Bowel Syndrome (IBS). The inFoods® IBS test identifies, on average, two to four specific foods that trigger a patient’s IBS symptoms, leading to a simple, highly targeted and actionable dietary plan. The new AI-backed Trigger...